Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
9.31 USD | -2.62% | -0.96% | +10.31% |
Mar. 26 | Guggenheim Initiates Voyager Therapeutics With Buy Rating, $22 Price Target | MT |
Mar. 19 | H.C. Wainwright Initiates Coverage on Voyager Therapeutics With Buy Rating, $30 Price Target | MT |
Financials (USD)
Sales 2024 * | 38.84M | Sales 2025 * | 51.19M | Capitalization | 506M |
---|---|---|---|---|---|
Net income 2024 * | -98M | Net income 2025 * | -106M | EV / Sales 2024 * | 4.87 x |
Net cash position 2024 * | 316M | Net cash position 2025 * | 373M | EV / Sales 2025 * | 2.58 x |
P/E ratio 2024 * |
-5.18
x | P/E ratio 2025 * |
-5.3
x | Employees | 162 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 82.67% |
Latest transcript on Voyager Therapeutics, Inc.
1 day | -2.62% | ||
1 week | -0.96% | ||
Current month | +11.90% | ||
1 month | +3.79% | ||
3 months | +5.68% | ||
6 months | +20.60% | ||
Current year | +10.31% |
Managers | Title | Age | Since |
---|---|---|---|
Alfred Sandrock
CEO | Chief Executive Officer | 67 | 22-02-28 |
Michael Higgins
CHM | Chairman | 61 | 15-07-21 |
Director of Finance/CFO | 55 | 22-09-18 |
Members of the board | Title | Age | Since |
---|---|---|---|
George Scangos
BRD | Director/Board Member | 75 | 23-05-08 |
James Geraghty
BRD | Director/Board Member | 70 | 13-12-31 |
Glenn F. Pierce
BRD | Director/Board Member | 68 | 17-01-04 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.05% | 2 M€ | -.--% | ||
0.01% | 0 M€ | 0.00% | - | |
0.00% | 36 M€ | +4.92% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 9.31 | -2.62% | 629,050 |
24-03-27 | 9.56 | -4.59% | 730,077 |
24-03-26 | 10.02 | +8.21% | 882,443 |
24-03-25 | 9.26 | +2.77% | 661,919 |
24-03-22 | 9.01 | -4.15% | 482,896 |
Delayed Quote Nasdaq, March 28, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.31% | 506M | |
+9.30% | 46.03B | |
+52.73% | 44.55B | |
+7.15% | 40.8B | |
-8.78% | 28.25B | |
+18.68% | 27.71B | |
-21.92% | 18.82B | |
+14.62% | 13.91B | |
+31.85% | 12.43B | |
+4.47% | 10.81B |